From January 2005 through July 2010, four hundred thirty-four consecutive patients with cervical radioculopathy or myelopathy underwent anterior cervical diskectomy and fusion at 1 institution. Patients who had a concomitant second spinal procedure, revision anterior cervical diskectomy and fusion, history of anemia or a hematologic condition, or intraoperative complications were excluded, leaving 372 patients for the study group. Data were collected on postoperative hematologic laboratory studies ordered (complete blood count, coagulation studies, type, screen), postoperative blood transfusions, and readmissions within 1 month for anemia or transfusion. Patients were divided into those with and those without postoperative hematologic studies: 290 patients (119 one-level, 133 two-level, 38 three-level anterior cervical diskectomy and fusion) and 82 patients (41 one-level and 41 two-level anterior cervical diskectomy and fusion), respectively. No patient in either group required postoperative blood transfusion or readmission within 1 month for hematologic issues or surgery-related complications.
For patients undergoing 1-, 2-, or 3-level anterior cervical diskectomy and fusion with no history of hematologic issues, routine postoperative hematologic laboratory studies may be deferred without affecting the incidence of postoperative blood transfusions or hematologic-related readmissions. The elimination of unnecessary routine studies may result in substantial health care cost savings.
A nterior cervical diskectomy and fusion remains one of the most commonly performed procedures in spine surgery. For select patients with cervical disk disease, anterior cervical diskectomy and fusion provides reliable symptom relief and improvement in quality of life. Increases in the number of anterior cervical diskectomy and fusion procedures performed annually have been associated with decreased length of hospital stays and, perhaps more importantly, decreases in complications. 1 As efforts to control health care spending reach the forefront of the political agenda, physicians are faced with the challenge of administering high-level patient care while minimizing associated health care expenditures.
Although the largest cost savings may come from the transition of anterior cervical diskectomy and fusion from a largely inpatient to an outpatient procedure, 2-5 the widespread adoption of this procedure as the standard of care has not occurred. Anterior cervical diskectomy and fusion has distinct risks that must be taken into consideration. Complications include intraoperative vascular injury, postoperative dysphagia, wound hematoma, recurrent laryngeal nerve palsy, esophageal or pharyngeal perforation, worsening myelopathy, hardware failure, pseudarthrosis, nerve damage, and paralysis. [6] [7] [8] [9] At most hospital centers, anterior cervical diskectomy and fusion remains an inpatient procedure, with an average length of stay of 20 hours to 4 days. 5 One area of potential cost containment is the routine ordering of postoperative hematologic studies. These studies, in addition to vital signs and the physical examination, are important for clinicians to determine whether a patient needs a blood transfusion to facilitate healing. However, in many settings, these studies are part of a standardized postoperative order set and are reflexively ordered without regard for necessity or specific patient-or surgeryrelated factors. The focus of the authors' investigation was to determine the necessity of routine postoperative hematologic laboratory studies in patients undergoing anterior cervical diskectomy and fusion for cervical radiculopathy or myelopathy. The authors hypothesized that for patients with no previously identified hematologic issues or intraoperative complications, such studies would not influence or alter patient care. More specifically, routine postoperative hematologic laboratory studies should not influence the incidence of postoperative blood transfusion or hematologic-related readmissions.
Materials and Methods

Patient Population
After receiving Institutional Review Board approval, the authors retrospectively reviewed their patient database and identified 434 consecutive patients with cervical radioculopathy or myelopathy who underwent anterior cervical diskectomy and fusion by fellowship-trained orthopedic spine surgeons from January 2005 through July 2010 at their institution. All fusions were performed using structural allograft and anterior cervical plate fixation. They excluded patients with another concomitant spinal procedure (eg, posterior cervical or lumbar surgery, revision anterior cervical diskectomy and fusion, partial corpectomy, history of anemia or hematologic condition) or reported intraoperative complications (eg, vascular injury and esophageal or pharyngeal perforation).
For each patient, the authors reviewed the complete medical record (consisting of electronically documented operative notes, discharge notes, and laboratory data) and collected data on patient demographics, the operating surgeon, number of levels involved, surgical complications, postoperative hematologic laboratory studies ordered at the discretion of the attending surgeon (complete blood count, coagulation studies, type, and screen), postoperative transfusions performed, and incidence of hospital readmissions within 1 month after surgery for anemia or transfusion.
Of the 434 initial patients, 372 patients (140 men and 232 women) met the inclusion criteria. Average age was 54.4 years (range, 26-89 years), average estimated blood loss was 46 mL (range, 15-500 mL), and average length of hospital stay was 1.7 days (range, 1-25 days). The study population was further divided into 2 groups: those with postoperative hematologic studies (290 patients; 119 one-level, 133 two-level, and 38 three-level anterior cervical diskectomy and fusion) and those without (82 patients; 41 one-level and 41 two-level anterior cervical diskectomy and fusion). No statistically significant differences were noted between groups in terms of age, sex, estimated blood loss, or length of stay (P..05) ( Table 1) . For patients undergoing 1-level anterior cervical diskectomy and fusion, women made up 64.7% and 43.9% of the groups with and without postoperative hematologic studies, respectively, which was considered a significant difference (P5.02) (Table 2). Differences in age, estimated blood loss, and length of stay were not significant (P..05). For patients undergoing 2-level anterior cervical diskectomy and fusion, no significant differences were noted between the 2 groups in terms of age, sex, estimated blood loss, or length of stay (P..05) ( Table  2) . When comparing 1-vs multilevel anterior cervical diskectomy and fusion procedures, the 1-level group had significantly less estimated blood loss (P,.01) and shorter length of stay (P5.04) ( Table 3) .
Statistical Analysis
Statistical analysis was performed using Student's t test to compare patients with and without routine postoperative hematologic laboratory studies with respect to the following variables: patient age and sex, levels of fusion, estimated blood loss, length of hospital stay, and the presence and absence of postoperative hematologic laboratory studies. Significance was set at P<.05.
The authors identified a primary and a secondary outcome variable in determining the necessity for postoperative hematologic laboratory studies: the need for a postoperative blood transfusion and the need for hospital readmission within 1 month postsurgery, respectively.
results
The presence or absence of a postoperative complete blood count did not alter the treatment of any patient in this study population. No complications or subsequent need for transfusion or laboratory studies were observed in patients without postoperative hematologic studies. No patient in either group required a postoperative blood transfusion or hospital read- n Feature Article mission within 1 month after surgery for hematologic issues. In addition, no patient received a prescription of ferrous sulfate for concerns of postoperative anemia.
discussion
As health care reform continues to alter the landscape of medical reimbursement, surgeons and medical centers need to streamline their methods in an effort to reduce medical costs. However, such decreases in health care costs must not come at the expense of excellent patient care. In all surgical specialties, especially orthopedic surgery, most health care costs are derived from the implants used. Currently, these costs are typically fixed. Therefore, near-term potential decreases in costs will likely be found in alterations to the preand postsurgical aspects of patient care.
Postoperative laboratory studies after surgical intervention are routine and common. However, their necessity for all surgical cases has not been proven. Frequently, these studies are part of a postoperative protocol, with little regard for patient-specific characteristics. One of the most commonly used postoperative hematologic laboratory studies is a complete blood count because it helps to diagnose acute postoperative anemia. The ability to identify postoperative anemia allows for early resuscitation, reduces the risk of secondary cardiac complications, and helps promote healing and overall recovery.
Common complications associated with anterior cervical diskectomy and fusion include, but are not limited to, intraoperative arterial and venous injury, postoperative dysphagia, wound hematoma, recurrent laryngeal nerve palsy, esophageal or pharyngeal perforation, worsening myelopathy, and allograft extrusion. [6] [7] [8] [9] To the authors' knowledge, postoperative anemia has not been previously reported as a common complication. A likely explanation is the relatively bloodless exposure in addition to the lack of exposed, decorticated bone during anterior cervical diskectomy and fusion. Hence, perioperative blood loss is usually scant. In the current study, no patient required a blood transfusion. The overall average estimated intraoperative blood loss was 46 mL (range, 15-500 mL). Multilevel anterior cervical diskectomy and fusion procedures were associated with a significantly larger estimated blood loss compared with 1-level procedures. These findings are not surprising given the increased complexity of the multilevel cases. However, the average estimated blood loss in the multilevel cases was still ,100 mL.
Delayed bleeding is a rare complication of anterior diskectomy and fusion; dissection of the superior thyroid artery and pseudoaneurym of the inferior thyroid artery have been described. 10, 11 Both of these complications were found at least 9 days postoperatively and after the patients had been discharged. Postoperative laboratory studies would likely have not revealed these vascular complications in the acute postoperative setting. However, surgeons must always be wary of possible vascular injury and therefore monitor vital signs in addition to patient-specific objective and subjective findings.
The findings in this study are consistent with those of previous studies in other fields of medicine focusing on the necessity of routine postoperative laboratory studies. Horowitz et al 12 reported that routine postoperative hemoglobin testing after uncomplicated elective Cesarean sections in low-risk women did not lead to blood transfusions in their patient population. The authors advocated that postoperative hemoglobin testing should be limited to women who had previous hematologic issues or baseline anemia and those with excessive intraoperative blood loss. Ransom et al 13 examined the usefulness of type and screening in women undergoing Cesarean section and found that most transfusions were related to identifiable risk factors. Skenderis et al 14 examined the usefulness of routine postoperative testing in patients undergoing resection for adenocarcinoma of the colon and rectum. Postoperative serum potassium and glucose in addition to hemoglobin measurements were the only values found to affect patient care. Postoperative hemoglobin measurements prompted blood transfusions in 8.3% of patients. The authors advocated streamlining postoperative studies to only those measurements that may lead to therapeutic intervention.
During the study period at the current authors' institution, the average cost of a complete blood count varied between $9.37 and $11.35, the cost of a coagulation panel was $5.49, and the cost of a type and screen was $4.35. These costs totaled $19.21 to $21.19 per patient. The literature reports an average length of stay between 2.38 and 5.71 days.
1 At the current authors' institution, average length of stay was 1.70 days (range, 1-25 days). In trying to estimate an overall cost, the authors assumed that the laboratory costs are consistent with the estimated national average, patients would receive daily complete blood counts, and patients staying .3 days would require a repeat coagulation panel and type and screen. The current authors also assumed that patients who received no postoperative hematologic laboratory studies would have only 1 preoperative complete blood count, coagulation panel, and type and screen. On the basis of the national average length of stay data, patients who undergo anterior cervical diskectomy and fusion and receive postoperative daily hematologic laboratory studies spend 1.67 to 3.72 times more on unnecessary laboratory work per admission than do patients undergoing anterior cervical diskectomy and fusion who receive no postoperative daily hematologic laboratory studies (average cost, $32.14-$36.85 and $67.69-$78.99, respectively). On the basis of the authors' length of stay data, cost savings per admission by eliminating unnecessary laboratory studies amounts to $6.59 to $17.36 per patient. However, extrapolated to include the total number of anterior cervical diskectomy and fusion procedures per-formed nationally and adjusted to include the average length of stay data, the total cost savings by eliminating unnecessary hematologic laboratory studies on patients undergoing anterior cervical diskectomy and fusion procedures ranges from $983,850 to $2,604,450 per year.
Given the current cost-conscious health care environment, the elimination of unnecessary postoperative hematologic laboratory studies for patients undergoing anterior cervical diskectomy and fusion is a tangible and reasonable way to promote cost savings without sacrificing patient care. The elimination of routine postoperative laboratory studies does not replace the monitoring of vital signs and other patient-specific objective and subjective measures. Full cost-savings analysis, which would include the interpretation of direct and indirect costs, such as implant choice, type of anesthesia, operative time, impact of complications, and return to work, was outside of the scope of this study. Yet, the authors showed in their analysis that eliminating unnecessary laboratory work maintains high-quality care while it decreases the length of stay and unnecessary costs.
An important limitation of the current study is that it focused on the need for immediate postoperative laboratory studies in a specific population: patients with no intraoperative complications or previous history of hematologic issues. Therefore, their conclusions are not generally applicable to all patients undergoing anterior cervical diskectomy and fusion. A prospective, multicenter study is needed to further delineate the usefulness of postoperative laboratory studies in all patients undergoing anterior cervical diskectomy and fusion.
conclusion
The current study represents the first step to definitively assess the necessity of postoperative laboratory studies in patients undergoing anterior cervical diskectomy and fusion. Additional studies are currently underway to determine the necessity of postoperative hematologic laboratory studies in other orthopedic procedures, such as posterior cervical surgery and lumbar spine decompression, as well as select peripheral joint procedures. Because these procedures are associated with low intraoperative blood loss and short hospital stays, they may represent additional procedures in which postoperative hematologic laboratory studies may be omitted to help reduce unnecessary medical care costs while maintaining quality. In this scenario, the cumulative savings to the health care system may be substantive.
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